The co-founder and former CEO of Seagen, which is now heading for a $43 billion takeover by Pfizer, has been keeping a low ...

A survey of thousands of people in England suggests it may be time to look again at how pharma manufacturers are delivering ...

As March has brought another National Kidney Month, and the recognition of World Kidney Day on March 9 th, it is critical to ...

Melinta – which has US right to Rezzayo (rezafungin) under license from Cidara – said the drug has become the first new ...

Enabling market access, policy, and delivery. 24th-25th April 2023, Brussels. Register here. Top 3 Reasons To Attend Cell and ...

One of the primary barriers to the growth of the digital health category around the world are fragmented, contradictory or ...

NICE has recommended that PTC Therapeutics’ gene therapy for ultra-rare disease aromatic L-amino acid decarboxylase (AADC) deficiency Upstaza be made available for NHS use in draft guidance. The ...

The FDA is due to make a decision on tofersen by 25th April, and Biogen’s interpretation of the meeting was that the overall ...

How immersive experiences and the metaverse benefit customer experience and operations’, indicated that many consumers ...

Sanofi and Regeneron acknowledged that testing their inflammatory disease blockbuster Dupixent in chronic obstructive ...

Plasma-derived therapies present unique life-saving opportunities for people with rare and complex diseases, but their main ...

Cost-effectiveness agency NICE says the tests – which produce results in under an hour from a urine sample – could speed up ...